Company
Headquarters: Zhongshan, China
Employees: 3,152
HK$1.20 Billion
HKD as of July 1, 2024
US$154.2 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also involved in the operation of chain and online pharmacies; manufacture and sale of food and Chinese herbs; and property management. As of December 31, 2020, it operated 366 self-operated chain pharmacies, including 325 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Zhongzhi Pharmaceutical Holdings Ltd has the following listings and related stock indices.
Stock: HKEX: 3737 wb_incandescent